Browse Category

Financial Forecasts 20 December 2025 - 21 December 2025

Lynas Rare Earths (ASX:LYC) Stock: Latest News, Share Price Drivers, and 2026 Forecasts (21 December 2025)

Lynas Rare Earths (ASX:LYC) Stock: Latest News, Share Price Drivers, and 2026 Forecasts (21 December 2025)

Lynas Rare Earths Limited heads into the final full trading week before Christmas with a rare combination of near-term index-driven momentum and very real operational risk—a classic recipe for volatility. On one hand, Lynas is set to join the S&P/ASX 50 effective before the open on Monday, 22 December 2025, a change that can trigger mechanical buying from index-tracking funds. Company Announcements On the other hand, the company has warned that power disruptions at its Kalgoorlie processing facility could translate into an output shortfall equivalent to about a month of production in the current quarter—exactly the kind of headline that makes short-term traders twitchy. Reuters
Tesla Stock (TSLA) News and Forecasts for Dec. 20, 2025: Musk’s Pay Deal Reinstated, Robotaxi Momentum, and Wall Street’s Split Outlook

Tesla Stock (TSLA) News and Forecasts for Dec. 20, 2025: Musk’s Pay Deal Reinstated, Robotaxi Momentum, and Wall Street’s Split Outlook

Tesla, Inc. heads into the weekend of December 20, 2025 with its stock hovering just below recent record territory after a headline-heavy week that mixed major corporate-governance news, fresh robotaxi milestones, and new analyst forecasts that underscore how sharply opinions diverge on what Tesla is really worth.
Shopify Stock (SHOP) News, Price Targets, and 2026 Outlook: Wall Street Upgrades Meet AI Push and Record Holiday Sales

Shopify Stock (SHOP) News, Price Targets, and 2026 Outlook: Wall Street Upgrades Meet AI Push and Record Holiday Sales

Dec. 20, 2025 — Shopify Inc. stock is closing out 2025 with momentum, but also with a growing debate around valuation and execution risk. After Friday’s close, SHOP is hovering near multi-month highs following a strong year for e-commerce software, fresh analyst price-target hikes, and a wave of December headlines spanning holiday spending data, a Cyber Monday disruption, and major AI-focused product launches.
Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining Company stock is ending 2025 in the spotlight—riding a historic surge in silver prices, fresh company catalysts in Nevada, and a looming index event that could reshape near-term trading flows. As of Dec. 20, 2025, HL is around $19.67 after a volatile day that pushed above $20.50. StockInvest
Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Dec. 20, 2025 — Intuit Inc. enters the weekend with investors balancing a fresh fintech headline—Intuit’s newly announced USDC stablecoin partnership with Circle—against the familiar seasonal catalyst that often defines the stock’s narrative: TurboTax demand heading into the 2026 filing season. Intuit Inc.+1
IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

International Business Machines Corporation enters the final stretch of 2025 with its stock consolidating near the $300 level—an area that has become a focal point for both bulls betting on IBM’s “AI + hybrid cloud” strategy and skeptics warning that the company’s acquisition push could strain the balance sheet.
Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close, Insmed shares finished at $174.84, up about 5% on the day—recovering some ground after Thursday’s steep drop.
Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

December 20, 2025 — Salesforce, Inc. stock is heading into the final stretch of 2025 at the center of a debate investors know well: is this a beaten-down software leader becoming a bargain again, or a “value trap” in a market that’s rewarding AI infrastructure over traditional SaaS? MarketWatch
Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

After reporting second-quarter fiscal 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston shares still fell sharply as investors zeroed in on what management said comes next: continued discounting, unfavorable price/mix, and higher international manufacturing costs that could keep profitability under pressure into the back half of the year. Barron's+2Reuters+2
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Dec. 20, 2025 — Eli Lilly and Company is closing out 2025 with momentum—and with fresh headlines that underscore why Eli Lilly stock has become one of the market’s most closely watched healthcare names. Shares last closed at $1,071.44 after trading between $1,059.01 and $1,075.38, keeping the stock within reach of its recent highs. Stock Analysis
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic “big-news repricing” behavior. Yahoo Finance
1 9 10 11 12 13 42
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY IN STAGES

AerCap

NYSE: AER 95 / 100
#2 BUY ON WEAKNESS

Xylem

NYSE: XYL 93 / 100
#3 ACCUMULATE

General Dynamics

NYSE: GD 91 / 100
#4 BUY WITH LIMITS

Visa

NYSE: V 88 / 100
#5 TACTICAL BUY

IDEX

NYSE: IEX 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.